Energy and Mammalian Target of Rapamycin Complex 1 (mTORC1) in Minimal Change Nephrotic Syndrome

Published on 02/05/2016 by admin

Filed under Nephrology

Last modified 03/05/2016

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 2.2 (34 votes)

This article have been viewed 2308 times

<

Buy Membership for Nephrology Category to continue reading. Learn more here

Related posts:

Default ThumbnailHistory of Research on Pathogenesis of Idiopathic Nephrotic Syndrome Default ThumbnailRegulatory T Cells and Oxidative Stress in Minimal Change Nephropathy Default ThumbnailCytokines as Active Factors in Focal Segmental Glomerulosclerosis Default ThumbnailSoluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis Default ThumbnailPodocytes as a Direct Target of Drugs Used in Idiopathic Nephrotic Syndrome Angiopoietin-Like 4 (Angptl4) in MCNS